Publications

Trujillo G, Meneghin A, Flaherty KR, Scholl LM, Myers JL, Kazerooni EA, Gross BH, Oak SR, Coelho AL, Evanoff HL, Day E, Toews GB, Joshi AD, Schaller MA, Waters B, Jarai G, Westwick J, Kunkel SL, Martinez FJ, Hogaboam CM. TLR9 differentiates rapidly from slowly progressive forms of idiopathic pulmonary fibrosis. Science Transl Med. 2010;2:57ra82. PMCID:PMC3235647.

Moreira AP, Cavassani KA, Ismailoglu UB, Hullinger R, Dunleavy M, Knight DA, Kunkel SL, Uematsu S, Akira S, Hogaboam CM. The protective role of TLR6 in a mouse model of asthma is mediated by IL-23 and IL-17A. J Clin Invest. 2011;121:4420–4432. PMCID:PMC3204826.

Damjanovic D, Lai R, Jeyanathan M, Hogaboam CM, Xing Z. Marked improvement of severe lung immunopathology by influenza-associated pneumococcal superinfection requires the control of both bacterial replication and host immune responses. Am J Pathol. 2013;183:868–880. PMID:23831294.

O’Dwyer DN, Armstrong ME, Trujillo G, Cooke G, Keane MP, Fallon PG, Simpson AJ, Millar AB, McGrath EE, Whyte MK, Hirani N, Hogaboam CM, Donnelly SC. The toll-like receptor 3 L4 12F polymorphism and disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2013;188(12):1442–1450. doi:10.1164/rccm.201304-0760OC

Kittan NA, Allen RM, Dhaliwal A, Cavassani KA, Schaller MA, Gallagher KA, Carson WF, Mukherjee S, Grembecka J, Cierpicki T, Jarai G, Westwick J, Kunkel SL, Hogaboam CM. Cytokine induced phenotypic and epigenetic signatures are key to establishing specific macrophage phenotypes. PLoS One. Oct 21, 2013;8(10):e78045. PMID:24205083.

Murray LA, Zhang H, Oak SR, Coelho AL, Herath A, Flaherty KR, Lee J, Bell M, Knight DA, Martinez FJ, Elias JA, Sleeman MA, Herzog EL, Hogaboam CM. Targeting interleukin-13 with tralokinumab attenuates lung fibrosis and epithelial damage in a humanized SCID idiopathic pulmonary fibrosis model. Am J Respir Cell Mol Biol. 2014;50(5):985–994. doi:10.1165/rcmb.2013-0342OC.

Habiel DM, Hogaboam CM. Heterogeneity in fibroblast proliferation and survival in idiopathic pulmonary fibrosis. Front Pharmacol. Jan 23, 2014;5:2. PMID:24478703.

Shibata T, Habiel DM, Coelho AL, Kunkel SL, Lukacs NW, Hogaboam CM. Axl receptor blockade ameliorates pulmonary pathology resulting from primary viral infection and viral exacerbation of asthma. J Immunol. 2014;192(8):3569–3581. PMID:24659691. 

Shibata T, Ismailoglu UB, Kittan NA, Moreira AP, Coelho AL, Chupp GL, Kunkel SL, Lukacs NW, Hogaboam CM. Role of Gas6 in the development of fungal allergic airway disease in mice. [Epub ahead of print May 2014] Am J Respir Cell Mol Biol. PMID:24810144.